🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Investigators propose to examine the effect of 12 weeks of Linagliptin, a d...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2013-10
Trial ID
NCT01969084
Treatments Being Tested
The overall goal of this project is to determine the effects of anti-cancer...
Status
Completed
Location
Lafene Health Center
Start Date
2017-02-01
Trial ID
NCT03062878
Microvascular dysfunctions are critical events in several diseases includin...
Status
Completed
Location
Laboratoire de Physiologie et Explorations Vasculaires - CHU Angers
Start Date
1996-01
Trial ID
NCT00152724
This is a prospective, observational study that will examine endothelial dy...
Status
Completed
Location
University of Pittsburgh Medical Center - Presbyterian University Hospital
Start Date
2019-05-01
Trial ID
NCT04128878
Treatments Being Tested
Vascular and neurological mechanisms are both likely to be involved in foot...
Status
Unknown
Location
Centre hospitalier universitaire
Start Date
2003-01
Trial ID
NCT00160927
Treatments Being Tested
In this study the investigators have aimed to evaluate morphology and react...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT02085317
Treatments Being Tested
Vitamin D is not seen anymore only as a phosphocalcic hormone, but also as ...
Status
Completed
Location
Hôpital Femme Mère Enfant
Start Date
2013-02
Trial ID
NCT01832623
Treatments Being Tested
The microcirculation plays a fundamental role in metabolic reactions and ha...
Status
Completed
Location
Maasstad Ziekenhuis
Start Date
2018-12-10
Trial ID
NCT04660162
Treatments Being Tested
SARS-CoV-2 enters human cells through the binding of the spike protein with...
Status
Completed
Location
UH Angers
Start Date
2021-10-22
Trial ID
NCT04773899
Treatments Being Tested